{"id":"continuous-oc-ee-dros","safety":{"commonSideEffects":[{"rate":null,"effect":"Breakthrough bleeding"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Mood changes"}]},"_chembl":{"chemblId":"CHEMBL1627464","moleculeType":"Small molecule","molecularWeight":"296.41"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This combination oral contraceptive works by delivering a continuous dose of ethinyl estradiol (a synthetic estrogen) and drospirenone (a progestin with antimineralocorticoid activity) to suppress the luteinizing hormone surge required for ovulation. The continuous formulation eliminates the hormone-free interval found in traditional cyclic pills, reducing breakthrough bleeding and providing consistent contraceptive coverage throughout the cycle.","oneSentence":"Continuous OC (EE/DROS) is an oral contraceptive containing ethinyl estradiol and drospirenone that prevents pregnancy through hormonal suppression of ovulation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:31:00.139Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception"},{"name":"Reduction of menstrual bleeding"}]},"trialDetails":[{"nctId":"NCT00927095","phase":"PHASE4","title":"Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2008-07","conditions":"Premenstrual Dysphoric Disorder","enrollment":67}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Yaz"],"phase":"marketed","status":"active","brandName":"Continuous OC (EE/DROS)","genericName":"Continuous OC (EE/DROS)","companyName":"University of North Carolina, Chapel Hill","companyId":"university-of-north-carolina-chapel-hill","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Continuous OC (EE/DROS) is an oral contraceptive containing ethinyl estradiol and drospirenone that prevents pregnancy through hormonal suppression of ovulation. Used for Contraception, Reduction of menstrual bleeding.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}